BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20483042)

  • 1. T cell signal transducer and activator of transcription (STAT) 4 and 6 are affected by adalimumab therapy in rheumatoid arthritis.
    Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
    Clin Exp Rheumatol; 2010; 28(2):208-14. PubMed ID: 20483042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of phospho-p38 mitogen-activated kinase (MAPK): p38 MAPK does not mediate the effect of adalimumab on peripheral T cell cytokine production in rheumatoid arthritis.
    Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
    Cytokine; 2009 Sep; 47(3):178-84. PubMed ID: 19616965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of cyclosporine A on the expression of T-bet, GATA-3, relevant signal transduction molecules, cytokine and Th1/Th2 balance in patients with chronic aplastic anemia].
    Li J; Zhou YM; Hu MH; Sun WL; Xue ZZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1211-9. PubMed ID: 21129263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression.
    Aerts NE; De Knop KJ; Leysen J; Ebo DG; Bridts CH; Weyler JJ; Stevens WJ; De Clerck LS
    Rheumatology (Oxford); 2010 Dec; 49(12):2264-72. PubMed ID: 20724433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
    Deboy CA; Xin J; Byram SC; Serpe CJ; Sanders VM; Jones KJ
    Exp Neurol; 2006 Sep; 201(1):212-24. PubMed ID: 16806176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered memory T cell differentiation in patients with early rheumatoid arthritis.
    Skapenko A; Wendler J; Lipsky PE; Kalden JR; Schulze-Koops H
    J Immunol; 1999 Jul; 163(1):491-9. PubMed ID: 10384153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.
    Dombrecht EJ; Aerts NE; Schuerwegh AJ; Hagendorens MM; Ebo DG; Van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    Clin Exp Rheumatol; 2006; 24(1):31-7. PubMed ID: 16539816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein immunomodulates the functional activities of macrophage and cytokines produced during ex vivo macrophage-CD4
    Benghalem I; Meziane W; Hadjidj Z; Ysmail-Dahlouk L; Belamri A; Mouhadjer K; Aribi M
    Cytokine; 2017 Aug; 96():59-70. PubMed ID: 28324804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis.
    Nozaki Y; Tamaki C; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
    Rheumatol Int; 2006 Jul; 26(9):810-7. PubMed ID: 16292516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4.
    Moriggl R; Kristofic C; Kinzel B; Volarevic S; Groner B; Brinkmann V
    J Immunol; 1998 Apr; 160(7):3385-92. PubMed ID: 9531298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
    Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
    Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
    Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
    Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
    Morinobu A; Wang Z; Kumagai S
    J Rheumatol; 2000 Apr; 27(4):851-8. PubMed ID: 10782806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interferon-gamma, interleukin-4 and interleukin-2 by Schizonepeta tenuifolia through differential effects on nuclear factor-kappaB, NFATc2 and STAT4/6.
    Kang H; Moon JY; Sohn NW
    Exp Biol Med (Maywood); 2010 Feb; 235(2):230-6. PubMed ID: 20404039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.
    Popa C; Barrera P; Joosten LA; van Riel PL; Kullberg BJ; van der Meer JW; Netea MG
    Eur Cytokine Netw; 2009 Jun; 20(2):88-93. PubMed ID: 19541595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis.
    Yamana J; Yamamura M; Okamoto A; Aita T; Iwahashi M; Sunahori K; Makino H
    Arthritis Res Ther; 2004; 6(6):R567-77. PubMed ID: 15535835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
    Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.